M-3274-A-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3PP5_Strong
The ENST00000386347.1(MT-TL1):n.45A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Mitomap GenBank:
Absent
Consequence
MT-TL1
ENST00000386347.1 non_coding_transcript_exon
ENST00000386347.1 non_coding_transcript_exon
Scores
Mitotip
Pathogenic
Clinical Significance
Neuropsychiatric-syndrome-+-cataract
Conservation
PhyloP100: 0.987
Genes affected
MT-TL1 (HGNC:7490): (mitochondrially encoded tRNA leucine 1 (UUA/G)) Implicated in cardiomyopathy. [provided by Alliance of Genome Resources, Apr 2022]
MT-ND1 (HGNC:7455): (mitochondrially encoded NADH dehydrogenase 1) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial membrane. Part of mitochondrial respiratory chain complex I. Implicated in several diseases, including MELAS syndrome; neurodegenerative disease (multiple); optic nerve disease (multiple); toxic shock syndrome; and type 2 diabetes mellitus. Biomarker of Alzheimer's disease; Parkinson's disease; and multiple sclerosis. [provided by Alliance of Genome Resources, Apr 2022]
MT-RNR2 (HGNC:7471): (mitochondrially encoded 16S RNA) Enables G protein-coupled receptor binding activity; protein self-association; and receptor antagonist activity. Involved in several processes, including leukocyte chemotaxis; negative regulation of cell death; and negative regulation of neuroinflammatory response. Located in several cellular components, including mitochondrion; perinuclear region of cytoplasm; and sperm midpiece. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM2
No frequency data in Mitomap. Probably very rare.
PP3
Mitotip and hmtvar scores support pathogenic criterium.
PP5
Variant M-3274-A-G is Pathogenic according to our data. Variant chrM-3274-A-G is described in ClinVar as [Uncertain_significance]. Clinvar id is 9598.Status of the report is reviewed_by_expert_panel, 3 stars. We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNL1 | TRNL1.1 use as main transcript | n.45A>G | non_coding_transcript_exon_variant | 1/1 | ||||
RNR2 | RNR2.1 use as main transcript | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-TL1 | ENST00000386347.1 | n.45A>G | non_coding_transcript_exon_variant | 1/1 | ||||||
MT-ND1 | ENST00000361390.2 | upstream_gene_variant | ENSP00000354687 | P1 | ||||||
MT-RNR2 | ENST00000387347.2 | downstream_gene_variant |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap
Neuropsychiatric-syndrome-+-cataract
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:2Uncertain:2
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Neuropsychiatric disorder and early-onset cataract Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 27, 2001 | - - |
MELAS syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Jul 12, 2019 | The NC_012920.1:m.3274A>G variant in MT-TL1 gene is interpreted to be a Pathogenic variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: PS3, PM7, PM8, PM9 - |
MERRF syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 23, 2022 | - - |
Mitochondrial disease Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen | Apr 23, 2024 | The m.3274A>G in MT-TL1 has been reported in one individual to date, in a man with a progressive neuropsychiatric disorder and multisystem organ involvement. At 12 years old, he had a decline in school performance. By his late 20s, he experienced acute psychotic symptoms and depression. He also had bilateral hearing loss, gait instability, and bilateral dysdiadokinesis. By his early 30s, he had cataracts, retinal degeneration, muscle weakness, ataxic gait, dysarthria, intention tremor, and dysmetria. Brain MRIs showed progressive cerebral and cerebellar atrophy and T2 hyperintense lesions in the basal ganglia. He had elevated blood and cerebrospinal fluid lactate. Muscle biopsy showed increased central nuclei and ragged red fibers, with reduced complex I activity (53% of lowest norm). The variant was present at 25% in muscle and undetectable in blood (PMID: 11723298). The variant was absent in blood from three healthy maternal family members, but this cannot be considered evidence of de novo status as the variant was also absent in the proband’s blood. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). Single fiber testing showed higher levels of the variant in ragged red fibers (55 ± 26.1%; N=22; mutant mtDNA found in every fiber) than in normal fibers (14 ± 25.7%; N=16; mutant mtDNA found in 7/16 fibers), p<0.001 (PS3_supporting, PMID: 11723298). The computational predictor MitoTIP suggests this variant is pathogenic (77.1 percentile) and HmtVAR predicts it to be pathogenic score of 0.55 (PP3). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on April 23, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting, PM2_supporting, PP3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Pathogenic
Hmtvar
Pathogenic
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at